EVE 0.00% 0.1¢ eve health group limited.

Ann: Appendix 4D and Half Year Report, page-3

  1. 145 Posts.
    lightbulb Created with Sketch. 5
    Nothing new or surprising that I can see. Potential Distribution deals all across Asia for Meluka Health seems to be the big one to watch out for.

    Jenbrook increasing production capability would be good. It's generating revenues, but we will want to see growth both Locally and international markets. The 49% share in NAP offers a launching pad for the full range of products in the US.
 
watchlist Created with Sketch. Add EVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.